share_log

Spyre Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Milligan Sandra

SEC ·  May 16 16:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more